The first is that DAB2IP is downregulated when cells are detached or grown at low density; this suggests that DAB2IP levels would drop in pre-metastatic cells that are pushed out of an epithelium during tumor growth, and this would facilitate the aberrant signaling of oncogenic pathways such as RAS and NF-kB. The gene discussed is DAB2IP; the disease is neoplasm.